France Advanced Therapy Medicinal Products CDMO Market (2025-2031) | Outlook, Analysis, Strategy, Forecast, Growth, Industry, Restraints, Companies, Revenue, Challenges, Size, Strategic Insights, Share, Supply, Investment Trends, Competition, Segments, Drivers, Segmentation, Trends, Value, Pricing Analysis, Demand, Competitive, Opportunities, Consumer Insights

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 France Country Macro Economic Indicators

3.2 France Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, 2021 & 2031F

3.3 France Advanced Therapy Medicinal Products CDMO Market - Industry Life Cycle

3.4 France Advanced Therapy Medicinal Products CDMO Market - Porter's Five Forces

3.5 France Advanced Therapy Medicinal Products CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.6 France Advanced Therapy Medicinal Products CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F

3.7 France Advanced Therapy Medicinal Products CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for advanced therapy medicinal products (ATMPs) in France due to rising prevalence of chronic diseases.

4.2.2 Favorable government regulations and policies supporting the development and manufacturing of ATMPs in France.

4.2.3 Growing investments in research and development by pharmaceutical companies to innovate in the field of ATMPs.

4.3 Market Restraints

4.3.1 High cost associated with the development and production of advanced therapy medicinal products.

4.3.2 Stringent regulatory requirements and complex approval processes for ATMPs in France.

6.1 France Advanced Therapy Medicinal Products CDMO Market, By Product Type

6.1.1 Overview and Analysis

6.1.2 France Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Product Type, 2021 - 2031F

6.1.3 France Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Gene Therapy, 2021 - 2031F

6.1.4 France Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Cell Therapy, 2021 - 2031F

6.1.5 France Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Tissue-Engineered Products, 2021 - 2031F

6.2 France Advanced Therapy Medicinal Products CDMO Market, By Service

6.2.1 Overview and Analysis

6.2.2 France Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Manufacturing, 2021 - 2031F

6.2.3 France Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Research & Development, 2021 - 2031F

6.2.4 France Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Others, 2021 - 2031F

6.3 France Advanced Therapy Medicinal Products CDMO Market, By End User

6.3.1 Overview and Analysis

6.3.2 France Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F

6.3.3 France Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Biotechnology Companies, 2021 - 2031F

6.3.4 France Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Hospitals & Clinics, 2021 - 2031F

7.1 France Advanced Therapy Medicinal Products CDMO Market Export to Major Countries

7.2 France Advanced Therapy Medicinal Products CDMO Market Imports from Major Countries

8.1 Number of clinical trials conducted for ATMPs in France.

8.2 Investment trends in ATMP manufacturing facilities and technologies in France.

8.3 Number of partnerships and collaborations between pharmaceutical companies and ATMP contract development and manufacturing organizations (CDMOs) in France.

9.1 France Advanced Therapy Medicinal Products CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.2 France Advanced Therapy Medicinal Products CDMO Market Opportunity Assessment, By Service, 2021 & 2031F

9.3 France Advanced Therapy Medicinal Products CDMO Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 France Advanced Therapy Medicinal Products CDMO Market Revenue Share, By Companies, 2024

10.2 France Advanced Therapy Medicinal Products CDMO Market Competitive Benchmarking, By Operating and Technical Parameters